INS and metabolic dysfunction-associated steatotic liver disease: Furthermore, there will be fat accumulation in the liver of patients with NAFLD, which may affect the normal insulin signal transmission and function, leading to the development of insulin resistance (IR) and thus increasing the risk of type II diabetes mellitus [11, 14, 15].